Mira Pharmaceuticals, Inc.
MIRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001904286
No open-market purchases or sales by Mira Pharmaceuticals, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $2.19M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Mira Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- 0 vs. Q1 2024
- Shares held
- 711.9K
- +71.0K (+11.1%) vs. Q1 2024
- Total value
- $454.0K
- −$250.0K (−35.5%) vs. Q1 2024
- New holders
- 4
- 1 more added
- Sold out
- 4
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $2.19M |
| Q1 2026 | 26 | $2.30M |
| Q4 2025 | 25 | $3.35M |
| Q3 2025 | 29 | $1.89M |
| Q2 2025 | 20 | $1.21M |
| Q1 2025 | 19 | $949.1K |
| Q4 2024 | 24 | $1.28M |
| Q3 2024 | 15 | $1.08M |
| Q2 2024 | 11 | $454.0K |
| Q1 2024 | 11 | $704.0K |
| Q4 2023 | 6 | $102.0K |
| Q3 2023 | 3 | $3.72K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Mira Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cross Staff Investments Inc | 383,401 | $244.2K | 0.20% | 00.0% | Unchanged |
| Avantax Planning Partners, Inc. | 118,751 | $75.6K | 0.00% | +118,751 | New |
| Suncoast Equity Management | 40,000 | $25.5K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 29,546 | $18.8K | 0.00% | +24,775+519.3% | Added |
| Praetorian Wealth Management, Inc. | 27,500 | $17.5K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 24,396 | $16.1K | 0.00% | +24,396 | New |
| Northern Trust Corp | 20,454 | $13.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 20,001 | $12.7K | 0.00% | +20,001 | New |
| First American Bank | 20,000 | $12.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 17,869 | $11.4K | 0.00% | +17,869 | New |
| Cary Street Partner Investment Advisory LLC | 10,000 | $6.37K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −63,055−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −30,651−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −25,544−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −15,573−100.0% | Sold out |